ELENA SALPAS: Open Payments
NPI 1518448463 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 37 payments from 11 companies in 2025. Trend: 2023 $206 · 2024 $1,294 · 2025 $926
Food & beverage: $854Education: $72
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $219 |
| Janssen Biotech, Inc. | 11 | $195 |
| Incyte Corporation | 5 | $192 |
| GENZYME CORPORATION | 4 | $96 |
| Galderma Laboratories, L.P. | 2 | $65 |
| ABBVIE INC. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Organon LLC | 1 | $15 |
Products named: TREMFYA, Opzelura, EBGLYSS, DUPIXENT, TALTZ, NEMLUVIO, SKYRIZI, Zoryve.
Industry payments across OR — which companies pay providers there.
